Pharmaceutical Law 2200-1PS013
thematic blocks:
1. Introduction to pharmaceutical law – concept, sources of law, relation to other branches of law.
2. Constitutional foundations – right to health, proportionality principle, economic freedom. EU and international dimensions of pharmaceutical law.
3. The concept of medicinal product and medical device – definitions, classification, borderline issues.
4. Institutions and authorities responsible for regulation – URPL (Office for Registration of Medicinal Products), GIF (Chief Pharmaceutical Inspector), Ministry of Health, EMA (European Medicines Agency).
5. Marketing authorisation procedures – national, decentralised, mutual recognition (MRP), and EU central procedure.
6. Wholesale and retail distribution of medicinal products – principles, licences, professional liability.
7. Advertising of medicinal products – legal boundaries, public vs. professional audience.
8. Reimbursement of medicinal products – reimbursement policy, reimbursement lists, decisions, criteria.
9. Availability of medicinal products and drug shortages – distribution duties, export bans.
10. Innovation in the pharmaceutical market – regulatory and financial incentives, data protection, clinical trials.
11. Pharmacopoeia and medicinal product quality – quality requirements, market supervision.
12. Drug safety and post-marketing surveillance (PhV – Pharmacovigilance).
13. Legal liability in pharmaceutical law – civil, criminal, administrative.
14. Current challenges and developments in pharmaceutical law – legislative changes, pandemic-related issues.
Type of course
Mode
Course coordinators
Learning outcomes
Upon completion of the course, the student:
• can interpret and apply pharmaceutical law regulations,
• knows the structure of the pharmaceutical market and the competences of regulatory bodies,
• understands the procedures for placing medicinal products on the market,
• knows the principles of drug reimbursement and advertising,
• can assess the compliance of entities’ actions with pharmaceutical law,
• understands the significance of constitutional guarantees regarding access to medicines,
• knows key case law and scholarly positions,
• is able to conduct legal analysis of pharmaceutical market cases.
Assessment criteria
Written test. Optional: preparation of a draft scientific article or legal commentary for publication.
Bibliography
• R. Stankiewicz, Model racjonalizacji dostępu do produktu leczniczego. Zagadnienia publicznoprawne, Warsaw 2014
• Instytucje rynku farmaceutycznego, ed. R. Stankiewicz, Warsaw 2016
• Commentaries to the Pharmaceutical Law Act, the Reimbursement Act, and the Act on Medical and Pharmaceutical Professions
Notes
Term 2025L:
None |
Additional information
Additional information (registration calendar, class conductors, localization and schedules of classes), might be available in the USOSweb system: